LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SG Americas Securities, LLC | 54,535 | $80 | 0.00% |
| MetLife Investment Management, LLC | 92,101 | $135,388 | 0.00% |
| AMERIPRISE FINANCIAL INC | 44,942 | $66,065 | 0.00% |
| STRS OHIO | 5,400 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 72,322 | $106,313 | 0.00% |
| CREDIT SUISSE AG/ | 131,040 | $192,629 | 0.00% |
| CITIGROUP INC | 193,739 | $284,796 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 106,695 | $156,842 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 33,000 | $48,510 | 0.00% |
| GOLDMAN SACHS GROUP INC | 537,617 | $790,297 | 0.00% |
| MORGAN STANLEY | 254,940 | $374,761 | 0.00% |
| Invesco Ltd. | 292,712 | $430,287 | 0.00% |
| AMALGAMATED BANK | 17,078 | $25 | 0.00% |
| MACKENZIE FINANCIAL CORP | 11,205 | $16,135 | 0.00% |
| ProShare Advisors LLC | 38,957 | $57,266 | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 36,546 | $53,723 | 0.00% |
| Mariner, LLC | 79,287 | $116,552 | 0.00% |
| Bank of New York Mellon Corp | 661,561 | $972,495 | 0.00% |
| Citadel Advisors | 10,200 | $14,994 | 0.00% |
| Citadel Advisors | 2,200 | $3,234 | 0.00% |
External links
This page lists LYELL IMMUNOPHARMA INC's shareholders in Q3 2023. To view LYELL IMMUNOPHARMA INC's shareholder history, click here.